Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Sarcoma 1

Conditions

Sarcoma 16Osteosarcoma 10Carcinosarcoma 9Neoplasm Metastasis 8Rhabdomyosarcoma 7Neuroblastoma 7Melanoma 6Lymphoma, Non-Hodgkin 6Endometrial Neoplasms 6Wilms Tumor 5Sarcoma, Ewing 5Rhabdoid Tumor 5Ovarian Neoplasms 5Lung Neoplasms 5Liposarcoma 5Leiomyosarcoma 5Histiocytosis, Langerhans-Cell 5Hepatoblastoma 5Gliosarcoma 5Glioblastoma 5Colorectal Neoplasms 5Carcinoma, Renal Cell 5Carcinoma, Non-Small-Cell Lung 5Carcinoma, Hepatocellular 5Sarcoma, Kaposi 4Neuroectodermal Tumors, Primitive, Peripheral 4Medulloblastoma 4Histiocytoma, Malignant Fibrous 4Glioma 4Ependymoma 4

Interventions

AZD 6244 3X-Rays 1Surgical Procedures, Operative 1Specimen Handling 1Sirolimus 1Radiotherapy 1Photons 1Magnetic Resonance Spectroscopy 1Liquid Biopsy 1Ifosfamide 1High-Energy Shock Waves 1Filgrastim 1Etoposide 1Doxorubicin 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurofibromatosis 1 × Specimen Handling × Sarcoma × Clear all
NCT02700230 2024-09-27

Vaccine Therapy in Treating Patients with Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by Surgery

Mayo Clinic

Phase 1 Completed
9 enrolled
CNSSarcoma

Neurofibromatosis 1, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡